VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Conditions:   Hematological Malignancy;   Acute Leukemia in Remission;   Acute Lymphoblastic Leukemia in Remission;   Myelodysplastic Syndromes;   Non-Hodgkin Lymphoma;   Hodgkin Lymphoma Interventions:   Biological: Cord blood stem cells;   Drug: Valproic Acid;   Drug: Fludarabine;   Drug: cytoxan;   Drug: Thiotepa;   Biological: TBI Sponsor:   Alla Keyzner Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials